Founded in 1915, H. Lundbeck A/S is a Danish pharmaceutical company dedicated to improving the quality of life for individuals suffering from psychiatric and neurological disorders. The company's core mission is to develop innovative treatments for conditions such as mood disorders, dementia, anxiety, and sleep disorders. Lundbeck conducts extensive research both in-house and in collaboration with global research centers, and it markets its products worldwide, focusing exclusively on brain diseases.
Lundbeck has made significant strides in the pharmaceutical industry, backed by notable investors and a strong presence on the Nasdaq Copenhagen stock exchange. The company has developed and commercialized several groundbreaking treatments over its century-long history. Its impact is evident in the improved lives of countless patients globally, solidifying Lundbeck's reputation as a leader in neuroscience and mental health treatment.
